(Q39419311)

11 September 2017

title

Immunization with the RrgB321 fusion protein protects mice against both high and low pilus-expressing Streptococcus pneumoniae populations (English)

1 reference

11 September 2017

0 references

Streptococcus pneumoniae

1 reference

1

Monica Moschioni

1 reference

11 September 2017

11

Vega Masignani

1 reference

11 September 2017

9

Michèle A Barocchi

1 reference

11 September 2017

Gabriella De Angelis

2

1 reference

11 September 2017

Carole Harfouche

3

1 reference

11 September 2017

Esmeralda Bizzarri

4

1 reference

11 September 2017

Sara Filippini

5

1 reference

11 September 2017

Elena Mori

6

1 reference

11 September 2017

Giuseppe Mancuso

7

1 reference

11 September 2017

Francesco Doro

8

1 reference

11 September 2017

Paolo Ruggiero

10

1 reference

11 September 2017

language of work or name

English

0 references

publication date

30 December 2011

1 reference

11 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

11 September 2017

volume

30

1 reference

11 September 2017

issue

7

1 reference

11 September 2017

page(s)

1349-1356

1 reference

Brief review of the clinical effectiveness of PREVENAR against otitis media

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Acute bacterial meningitis in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Recent advances in otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Pathogenesis, treatment, and prevention of pneumococcal pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Serotype replacement in perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Pneumococcal vaccines: an update on current strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Streptococcus pneumoniae pilus subunits protect mice against lethal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

The presence of the pilus locus is a clonal property among pneumococcal invasive isolates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally related

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Prevalence of pilus-encoding islets among acute otitis media Streptococcus pneumoniae isolates from Israel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

The Streptococcus pneumoniae pilus-1 displays a biphasic expression pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Expression of the type 1 pneumococcal pilus is bistable and negatively regulated by the structural component RrgA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Development of competence in Streptococcus pneumonaie: pheromone autoinduction and control of quorum sensing by the oligopeptide permease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

A pneumococcal pilus influences virulence and host inflammatory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Genomic organization, structure, regulation and pathogenic role of pilus constituents in major pathogenic Streptococci and Enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Meningococcal interactions with the host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

Pili in Gram-negative and Gram-positive bacteria - structure, assembly and their role in disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.080

10.1016/J.VACCINE.2011.12.080

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference